Johnson SW - Search Results

1

Gene expression profiling of human ovarian tumours.

Biade S, Marinucci M, Schick J, Roberts D, Workman G, Sage EH, O'Dwyer PJ, Livolsi VA, Johnson SW. Biade S, et al. Among authors: johnson sw. Br J Cancer. 2006 Oct 23;95(8):1092-100. doi: 10.1038/sj.bjc.6603346. Epub 2006 Sep 12. Br J Cancer. 2006. PMID: 16969345 Free PMC article.

2

Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells.

Roberts D, Schick J, Conway S, Biade S, Laub PB, Stevenson JP, Hamilton TC, O'Dwyer PJ, Johnson SW. Roberts D, et al. Among authors: johnson sw. Br J Cancer. 2005 Mar 28;92(6):1149-58. doi: 10.1038/sj.bjc.6602447. Br J Cancer. 2005. PMID: 15726096 Free PMC article.

3

Macrophage migration inhibitory factor is a determinant of hypoxia-induced apoptosis in colon cancer cell lines.

Yao K, Shida S, Selvakumaran M, Zimmerman R, Simon E, Schick J, Haas NB, Balke M, Ross H, Johnson SW, O'Dwyer PJ. Yao K, et al. Among authors: johnson sw. Clin Cancer Res. 2005 Oct 15;11(20):7264-72. doi: 10.1158/1078-0432.CCR-05-0135. Clin Cancer Res. 2005. PMID: 16243796

4

Evidence for altered regulation of gamma-glutamylcysteine synthetase gene expression among cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines.

Yao KS, Godwin AK, Johnson SW, Ozols RF, O'Dwyer PJ, Hamilton TC. Yao KS, et al. Among authors: johnson sw. Cancer Res. 1995 Oct 1;55(19):4367-74. Cancer Res. 1995. PMID: 7671249

5

Current status of oxaliplatin in colorectal cancer.

O'Dwyer PJ, Johnson SW. O'Dwyer PJ, et al. Among authors: johnson sw. Semin Oncol. 2003 Jun;30(3 Suppl 6):78-87. doi: 10.1016/s0093-7754(03)00215-x. Semin Oncol. 2003. PMID: 12802798 Review.

6

Clinical pharmacokinetics and administration of established platinum drugs.

O'Dwyer PJ, Stevenson JP, Johnson SW. O'Dwyer PJ, et al. Among authors: johnson sw. Drugs. 2000;59 Suppl 4:19-27. doi: 10.2165/00003495-200059004-00003. Drugs. 2000. PMID: 10864227 Review.

7

Decreased expression of retinol-binding proteins is associated with malignant transformation of the ovarian surface epithelium.

Roberts D, Williams SJ, Cvetkovic D, Weinstein JK, Godwin AK, Johnson SW, Hamilton TC. Roberts D, et al. Among authors: johnson sw. DNA Cell Biol. 2002 Jan;21(1):11-9. doi: 10.1089/10445490252810276. DNA Cell Biol. 2002. PMID: 11879576

8

The chemopreventive agent oltipraz stimulates repair of damaged DNA.

O'Dwyer PJ, Johnson SW, Khater C, Krueger A, Matsumoto Y, Hamilton TC, Yao KS. O'Dwyer PJ, et al. Among authors: johnson sw. Cancer Res. 1997 Mar 15;57(6):1050-3. Cancer Res. 1997. PMID: 9067269

9

Gene expression profiling of malignant mesothelioma.

Singhal S, Wiewrodt R, Malden LD, Amin KM, Matzie K, Friedberg J, Kucharczuk JC, Litzky LA, Johnson SW, Kaiser LR, Albelda SM. Singhal S, et al. Among authors: johnson sw. Clin Cancer Res. 2003 Aug 1;9(8):3080-97. Clin Cancer Res. 2003. PMID: 12912960

10

Determinants of cisplatin sensitivity in normal versus spontaneously transformed rat ovarian surface epithelial cells.

Perez RP, Johnson SW, Handel LM, O'Dwyer PJ, Hamilton TC. Perez RP, et al. Among authors: johnson sw. Gynecol Oncol. 1995 Sep;58(3):312-8. doi: 10.1006/gyno.1995.1236. Gynecol Oncol. 1995. PMID: 7672697

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters